Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CORRESPONDENCE
Year : 2018  |  Volume : 14  |  Issue : 12  |  Page : 1227-1229

Fatal interstitial lung disease associated with AZD9291


1 Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou 215000, China
2 Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou 215000, China

Correspondence Address:
Yan-bin Chen
Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, 899#, Pinghai Road, Suzhou 215000
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.199380

Rights and Permissions

AZD9291 is one of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC). Interstitial lung disease (ILD) induced by AZD9291 is very seldom. We provide a case of NSCLC treated with AZD9291 who developed ILD and died in order to improve the knowledge on AZD9291.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1002    
    Printed70    
    Emailed0    
    PDF Downloaded70    
    Comments [Add]    

Recommend this journal